182493230
liked
$Micron Technology(MU.US$
After financial results were announced, it exploded outside of hours
The semiconductor industry's financial results are still strong
Bloomberg ← Notes
After financial results were announced, it exploded outside of hours
The semiconductor industry's financial results are still strong
Bloomberg ← Notes
Translated
4
2
182493230
liked and commented on
Amgen has been on a downward trend for a while. If you get out of here, you'll go up there, right? It would be nice if there was a function that would let you know 🔔 when you break through this trend line.
Translated
1
3
182493230
reacted to and commented on
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
182493230
commented on
3/21 is a futures super trend.
I'm going to buy for 40338 yen, but I kept above this in the morning, and as of 9:30, it's a last-minute battle and defense, but the Buy and Sell rolls are repeated. However, this is also a closing price judgment, so let's see if we can stand above 40338 yen at 15:15 today.
If it passes through the Bank of Japan and FOMC and comes back to a buy turn, the long-term uptrend will continue, and the recent decline will have been impressive...
I'm going to buy for 40338 yen, but I kept above this in the morning, and as of 9:30, it's a last-minute battle and defense, but the Buy and Sell rolls are repeated. However, this is also a closing price judgment, so let's see if we can stand above 40338 yen at 15:15 today.
If it passes through the Bank of Japan and FOMC and comes back to a buy turn, the long-term uptrend will continue, and the recent decline will have been impressive...
Translated
4
1
182493230
liked
$Direxion Daily Semiconductor Bear 3x Shares ETF(SOXS.US$
Semiconductors are too strong
What should I do![]()
Semiconductors are too strong
What should I do
Translated
3
1
182493230
liked and commented on
The predicted value is around 146.90. The median price is around 146.81.
I think the movement of the images I draw is close to what I expected, albeit in every detail. I'm not saying that how to assume the range until the middle price is one strategy, because if you get on with the situation, you'll get a terrible back and forth... Or rather, if you're that bossy, you should make an entry, get burned, just watch it because you're scared, it's always being watched, and for example, it's normal that even though the market price is rising, it starts to drop once you make an entry, but I think it's absolutely strange. How much is FX losing...
I think the movement of the images I draw is close to what I expected, albeit in every detail. I'm not saying that how to assume the range until the middle price is one strategy, because if you get on with the situation, you'll get a terrible back and forth... Or rather, if you're that bossy, you should make an entry, get burned, just watch it because you're scared, it's always being watched, and for example, it's normal that even though the market price is rising, it starts to drop once you make an entry, but I think it's absolutely strange. How much is FX losing...
Translated
3
1
182493230
liked and commented on
$Novo-Nordisk A/S(NVO.US$ $Eli Lilly and Co(LLY.US$
Wall Street analysts say that as they continue to raise sales expectations for Eli Lilly's obesity medication, more companies are preparing to take the Zepbound seat.
Lily and its competitor Novo Nordisk have conquered and will continue to dominate the field of highly effective obesity medications. However, other competitor drugs are beginning to emerge from the lab, and when they hit the market, there is a possibility that Zepbound and Novo's Wegovy will be rejected.
Competition has intensified because slimming drugs make money![]()
Wall Street analysts say that as they continue to raise sales expectations for Eli Lilly's obesity medication, more companies are preparing to take the Zepbound seat.
Lily and its competitor Novo Nordisk have conquered and will continue to dominate the field of highly effective obesity medications. However, other competitor drugs are beginning to emerge from the lab, and when they hit the market, there is a possibility that Zepbound and Novo's Wegovy will be rejected.
Competition has intensified because slimming drugs make money
Translated
4
1
182493230
commented on
182493230
liked
This is a really earnest wish
It's decided that if you have money to live without losing just by listening, it's better not to lose it
That's the basis of financial inclusion
There are also many strange scams, and there are also people who try to make money by using photos of famous people in advertisements without permission
There are also people who don't mind boating and trying to get money
Please check carefully!
It's decided that if you have money to live without losing just by listening, it's better not to lose it
That's the basis of financial inclusion
There are also many strange scams, and there are also people who try to make money by using photos of famous people in advertisements without permission
There are also people who don't mind boating and trying to get money
Please check carefully!
Translated
9
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)